Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.268
Abstract: Background Recent studies have shown that using absolute lymphocyte count (ALC) based dosing of ATG (anti-thymoglobulin) can improve survival after allogeneic hematopoietic cell transplantation (Allo–HCT). At our center we routinely use a combination of ATG + post-transplant…
read more here.
Keywords:
gvhd prophylaxis;
atg;
allo hct;
Sign Up to like & get
recommendations!
0
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.289
Abstract: Background A combination of calcineurin inhibitor and methotrexate (MTX) is one of a standard GVHD prophylaxis in allogeneic hematopoietic stem cell transplantation. However, MTX delays engraftment particularly in cord blood transplantation (CBT). Methods We conducted…
read more here.
Keywords:
mtx;
gvhd prophylaxis;
mtx group;
mini mtx ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.441
Abstract: Background Our group previously reported a 16% incidence of HC after hematopoietic cell transplantation (HCT) involving mostly matched unrelated donors (85%) and ATG-containing regimens (80%) (Silva, Haematologica 2010). PT-Cy is an effective GVHD prophylaxis in…
read more here.
Keywords:
gvhd prophylaxis;
conditioning regimen;
cystitis;
group ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.455
Abstract: Introduction ATG and PTCy have been individually shown to reduce rates of GVHD in allogeneic transplants. We adopted a combination regimen of ATG and PT-Cy for GVHD prophylaxis in allogenic transplants for high risk hematological…
read more here.
Keywords:
high risk;
gvhd prophylaxis;
gvhd;
risk hematological ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-01204-7
Abstract: Post-transplant cyclophosphamide (PTCy) graft vs. host disease (GVHD) prophylaxis was initially developed in order to mitigate an excessive risk of acute and chronic GVHD associated with the use of haploidentical donor graft in allogeneic transplantation.…
read more here.
Keywords:
use;
gvhd prophylaxis;
group;
gvhd ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-021-01528-y
Abstract: Post-transplant cyclophosphamide (PTCy) combined with tacrolimus (TAC) as graft-versus-host disease (GvHD) prophylaxis post-hematopoietic cell transplantation (HCT) is safe and effective. Optimal serum levels of TAC in this combination remain undetermined. We hypothesized that TAC at…
read more here.
Keywords:
post transplant;
gvhd prophylaxis;
post;
gvhd ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Pediatrics International"
DOI: 10.1111/ped.13940
Abstract: methotrexate (MTX) was not used for GVHD prophylaxis. The present patient developed PES followed by severe GVHD. Both high numbers of transfused cord blood cells and GVHD prophylaxis without MTX are risk factors for PES,…
read more here.
Keywords:
severe gvhd;
gvhd prophylaxis;
two pediatric;
diverticulitis two ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-111955
Abstract: Background ATG and post-transplant cyclophosphamide (PT-Cy) have been individually shown to be efficacious in reducing rates of GVHD in HLA matched and mismatched transplants. We adopted a combination regimen of ATG and PT-Cy for GVHD…
read more here.
Keywords:
gvhd prophylaxis;
post transplant;
gvhd;
day ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-124849
Abstract: Background: Post-transplant high dose cyclophosphamide (PT-CY) effectively prevents graft-versus-host disease (GVHD) after unmanipulated HLA-haploidentical hematopoietic stem cell transplantation (HSCT). The use of PT-CY in HLA-identical donor is less explored. In this study, we analyzed the…
read more here.
Keywords:
gvhd prophylaxis;
group;
donor;
atg group ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-125209
Abstract: Background Human herpesvirus-6 (HHV-6) encephalitis occurs frequently through cord blood transplantation (CBT), and leads to a high risk of mortality and morbidity. Although CBT is a known risk factor for HHV-6 encephalitis, a thorough analysis…
read more here.
Keywords:
hhv encephalitis;
gvhd prophylaxis;
group;
hhv ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2020003779
Abstract: The introduction of posttransplant cyclophosphamide (PTCy) made performing allogeneic hematopoietic cell transplantation (HCT) from HLA haplotype-incompatible donors possible. In a setting of PTCy and tacrolimus/mycophenolate mofetil (MMF) as a graft-versus-host disease (GVHD) prophylaxis, a peripheral…
read more here.
Keywords:
trial;
ptcy;
sirolimus mmf;
gvhd prophylaxis ... See more keywords